Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Early balding at 40 increases prostate cancer risk.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Hair loss gene linked to prostate issues.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Higher DHT in male baldness may protect against prostate cancer.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.